Orthofix International | OFIX - Cash And Equivalent


Orthofix International reported $103.81M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Accuray USD 41.29M 22.05M Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 77.32M 21.55M Jun/2026
AtriCure USD 167.79M 21.62M Jun/2026
Dexcom USD 1.1B 13.2M Jun/2026
EDAP TMS EUR 15.01M 14.82M Mar/2026
Globus Medical USD 507.74M 53.2M Jun/2026
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 534.9M 54.5M Jun/2026
Integra LifeSciences USD 214.42M 22.39M Jun/2026
J&J USD 20.42B 1.27B Jun/2026
Medtronic USD 1.15B 135M Dec/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 103.81M 16.47M Jun/2026
Plus Therapeutics USD 2.37M 656K Jun/2026
STAAR Surgical USD 148.58M 16.72M Jun/2026
Stryker USD 3.39B 513M Jun/2026
Tandem Diabetes Care USD 62.82M 116.51M Jun/2026
Teleflex USD 300.16M 9.25M Jun/2026
Veracyte USD 299.52M 36.38M Jun/2026
Zimmer Biomet Holdings USD 410M 14.2M Jun/2026